{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:24:24Z","timestamp":1787657064155,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006334","name":"Uniwersytet Jana Kochanowskiego w Kielcach","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"DOI":"10.1007\/s10096-026-05642-x","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:16:07Z","timestamp":1787656567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Significant changes in the fecal bacteriobiota richness and diversity in patients with relapsing-remitting multiple sclerosis compared to healthy individuals"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2751-7304","authenticated-orcid":false,"given":"Julia","family":"Dul\u0119bska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-9896","authenticated-orcid":false,"given":"El\u017cbieta","family":"Jasi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9153-2250","authenticated-orcid":false,"given":"Monika","family":"Wawszczak-Kasza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3776-9701","authenticated-orcid":false,"given":"Jakub","family":"Bia\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0598-2002","authenticated-orcid":false,"given":"Kamila","family":"Koca\u0144da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-0380","authenticated-orcid":false,"given":"Edyta","family":"Suliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6129-0492","authenticated-orcid":false,"given":"Wioletta","family":"Adamus-Bia\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"3","key":"5642_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278\u2013286","journal-title":"Neurology"},{"key":"5642_CR2","unstructured":"Number of people with MS | Atlas of MS [Internet]. [cited 2026 Mar 21]. Available from: https:\/\/atlasofms.org\/map\/global\/epidemiology\/number-of-people-with-ms"},{"key":"5642_CR3","doi-asserted-by":"publisher","first-page":"100977","DOI":"10.1016\/j.lanepe.2024.100977","volume":"44","author":"E Portaccio","year":"2024","unstructured":"Portaccio E, Magyari M, Havrdova EK et al (2024) Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. Lancet Reg Health Eur 44:100977","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"5642_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD (2021) Diagnosis and Treatment of Multiple Sclerosis: A Review. JAMA 325(8):765\u2013779","journal-title":"JAMA"},{"issue":"4","key":"5642_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","volume":"22","author":"F Aloisi","year":"2023","unstructured":"Aloisi F, Giovannoni G, Salvetti M (2023) Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol 22(4):338\u2013349","journal-title":"Lancet Neurol"},{"issue":"7","key":"5642_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2174\/1570159X19666210629145351","volume":"20","author":"X Wang","year":"2022","unstructured":"Wang X, Liang Z, Wang S et al (2022) Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications. Curr Neuropharmacol 20(7):1413\u20131426","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"5642_CR7","doi-asserted-by":"publisher","first-page":"e00338","DOI":"10.1128\/CMR.00338-20","volume":"35","author":"SG Sorboni","year":"2022","unstructured":"Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R et al (2022) A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clin Microbiol Rev 35(1):e00338\u2013e00320","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"5642_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jfda.2018.12.012","volume":"27","author":"RX Ding","year":"2019","unstructured":"Ding RX, Goh WR, Wu RN et al (2019) Revisit gut microbiota and its impact on human health and disease. J Food Drug Anal 27(3):623\u2013631","journal-title":"J Food Drug Anal"},{"key":"5642_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev-immunol-101320-014237","volume":"40","author":"LW Yu","year":"2022","unstructured":"Yu LW, Agirman G, Hsiao EY (2022) The Gut Microbiome as a Regulator of the Neuroimmune Landscape. Annu Rev Immunol 40:143\u2013167","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"5642_CR10","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1007\/s00210-025-04776-7","volume":"399","author":"M Aijaz","year":"2026","unstructured":"Aijaz M, Ahmad M, Ahmad S et al (2026) The gut\u2013brain axis: role of gut microbiota in neurological disease pathogenesis and pharmacotherapeutics. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 399(4):4879\u20134905","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"1","key":"5642_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/imr.13343","volume":"325","author":"TL Montgomery","year":"2024","unstructured":"Montgomery TL, Peipert D, Krementsov DN (2024) Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet. Immunol Rev 325(1):131\u2013151","journal-title":"Immunol Rev"},{"issue":"2","key":"5642_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"issue":"8","key":"5642_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR et al (2019) Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 37(8):852\u2013857","journal-title":"Nat Biotechnol"},{"key":"5642_CR14","doi-asserted-by":"publisher","first-page":"1289683","DOI":"10.3389\/fmicb.2023.1289683","volume":"14","author":"A Dziuba","year":"2023","unstructured":"Dziuba A, Dzier\u017cak S, Sodo A et al (2023) Comparative study of virulence potential, phylogenetic origin, CRISPR-Cas regions and drug resistance of Escherichia coli isolates from urine and other clinical materials. Front Microbiol 14:1289683","journal-title":"Front Microbiol"},{"issue":"3","key":"5642_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/j.1538-7305.1948.tb01338.x","volume":"27","author":"CE Shannon","year":"1948","unstructured":"Shannon CE (1948) A mathematical theory of communication. Bell Syst Tech J 27(3):379\u2013423","journal-title":"Bell Syst Tech J"},{"issue":"12","key":"5642_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550","journal-title":"Genome Biol"},{"issue":"1","key":"5642_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/21505594.2019.1596507","volume":"10","author":"W Adamus-Bia\u0142ek","year":"2019","unstructured":"Adamus-Bia\u0142ek W, Wawszczak M, Arabski M et al (2019) Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains. Virulence 10(1):260\u2013276","journal-title":"Virulence"},{"issue":"13","key":"5642_CR18","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/cells12131760","volume":"12","author":"A Dunalska","year":"2023","unstructured":"Dunalska A, Saramak K, Szejko N (2023) The Role of Gut Microbiome in the Pathogenesis of Multiple Sclerosis and Related Disorders. Cells 12(13):1760","journal-title":"Cells"},{"issue":"9","key":"5642_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","volume":"18","author":"J Correale","year":"2022","unstructured":"Correale J, Hohlfeld R, Baranzini SE (2022) The role of the gut microbiota in multiple sclerosis. Nat Rev Neurol 18(9):544\u2013558","journal-title":"Nat Rev Neurol"},{"key":"5642_CR20","doi-asserted-by":"publisher","first-page":"12015","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi S, Gandhi R, Cox LM et al (2016) Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7:12015","journal-title":"Nat Commun"},{"key":"5642_CR21","doi-asserted-by":"publisher","first-page":"1681342","DOI":"10.3389\/fimmu.2025.1681342","volume":"16","author":"V Ticha","year":"2025","unstructured":"Ticha V, Coufal S, Jiraskova Zakostelska Z et al (2025) The gut microbiota composition is shaped by disease activity and individual treatment responses in patients with multiple sclerosis. Front Immunol 16:1681342","journal-title":"Front Immunol"},{"key":"5642_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13073-024-01364-x","volume":"16","author":"Q Lin","year":"2024","unstructured":"Lin Q, Dorsett Y, Mirza A et al (2024) Meta-analysis identifies common gut microbiota associated with multiple sclerosis. Genome Med 16:94","journal-title":"Genome Med"},{"key":"5642_CR23","doi-asserted-by":"publisher","first-page":"578087","DOI":"10.1016\/j.jneuroim.2023.578087","volume":"378","author":"V Vacaras","year":"2023","unstructured":"Vacaras V, Muresanu DF, Buzoianu AD et al (2023) The role of multiple sclerosis therapies on the dynamic of human gut microbiota. J Neuroimmunol 378:578087","journal-title":"J Neuroimmunol"},{"key":"5642_CR24","doi-asserted-by":"crossref","unstructured":"Zhang X, Wei Z, Liu Z et al (2024) Changes in gut microbiota in patients with multiple sclerosis based on 16s rRNA gene sequencing technology: a review and meta-analysis. J Integr Neurosci. ;23(7)","DOI":"10.31083\/j.jin2307127"},{"issue":"5","key":"5642_CR25","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/genes13050930","volume":"13","author":"V Navarro-L\u00f3pez","year":"2022","unstructured":"Navarro-L\u00f3pez V, M\u00e9ndez-Miralles M\u00c1, Vela-Yebra R et al (2022) Gut Microbiota as a Potential Predictive Biomarker in Relapsing-Remitting Multiple Sclerosis. Genes 13(5):930","journal-title":"Genes"},{"key":"5642_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.copbio.2016.11.010","volume":"44","author":"ML Marco","year":"2017","unstructured":"Marco ML, Heeney D, Binda S et al (2017) Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol 44:94\u2013102","journal-title":"Curr Opin Biotechnol"},{"issue":"11","key":"5642_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/jnnp-2018-320189","volume":"90","author":"S Simpson","year":"2019","unstructured":"Simpson S, Wang W, Otahal P et al (2019) Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis. J Neurol Neurosurg Psychiatry 90(11):1193\u20131200","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"5642_CR28","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1073\/pnas.0901529106","volume":"106","author":"MA Mahowald","year":"2009","unstructured":"Mahowald MA, Rey FE, Seedorf H et al (2009) Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA 106(14):5859\u20135864","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"5642_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, Raoul P, Cintoni M et al (2019) What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms 7(1):14","journal-title":"Microorganisms"},{"key":"5642_CR30","doi-asserted-by":"publisher","first-page":"28484","DOI":"10.1038\/srep28484","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J, Chia N, Kalari KR et al (2016) Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 6:28484","journal-title":"Sci Rep"},{"issue":"4","key":"5642_CR31","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1007\/s11427-024-2653-2","volume":"68","author":"J Feng","year":"2025","unstructured":"Feng J, Tang S, Yang X et al (2025) Landscapes of gut microbiome and blood metabolomic signatures in relapsing remitting multiple sclerosis. Sci China Life Sci 68(4):1042\u20131056","journal-title":"Sci China Life Sci"},{"issue":"6","key":"5642_CR32","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/ana.25244","volume":"83","author":"SK Tankou","year":"2018","unstructured":"Tankou SK, Regev K, Healy BC et al (2018) A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol 83(6):1147\u20131161","journal-title":"Ann Neurol"},{"key":"5642_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-022-01148-1","volume":"15","author":"F Thirion","year":"2023","unstructured":"Thirion F, Sellebjerg F, Fan Y et al (2023) The gut microbiota in multiple sclerosis varies with disease activity. Genome Med 15:1","journal-title":"Genome Med"},{"key":"5642_CR34","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3389\/fmicb.2020.02065","volume":"11","author":"M Desvaux","year":"2020","unstructured":"Desvaux M, Dalmasso G, Beyrouthy R et al (2020) Pathogenicity Factors of Genomic Islands in Intestinal and Extraintestinal Escherichia coli. Front Microbiol 11:2065","journal-title":"Front Microbiol"},{"key":"5642_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13099-019-0290-0","volume":"11","author":"J Sarowska","year":"2019","unstructured":"Sarowska J, Futoma-Koloch B, Jama-Kmiecik A et al (2019) Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog 11:10","journal-title":"Gut Pathog"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05642-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:16:10Z","timestamp":1787656570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05642-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":35,"alternative-id":["5642"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05642-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"11 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Bioethics Committee at the Collegium Medicum, Jan Kochanowski University of Kielce, Poland; Resolutions: No. 56\/2022 of November 4, 2022, and it was conducted in accordance with applicable data protection regulations. All participants provided written informed consent prior to inclusion.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}